Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05349084 · ClinicalTrials.gov registry record · NA

PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR

A NA study of Coronary Artery Disease, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT05349084 is a NA study of Coronary Artery Disease that has completed, run by Washington University School of Medicine. The registered enrollment target is 21 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05349084, a NA study of Coronary Artery Disease, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The broad, long-term objective of this pilot study is to develop an optimal, clinically usable, non-invasive evaluation of Coronary Artery Disease (CAD) in the setting of stable angina which provides both anatomic and functional information. Patients already scheduled to undergo Invasive coronary catheterization (ICA) for the clinical indication of angina will be recruited to under go stress-rest Positron Emission Tomography-Coronary CT Angiography-Fractional Flow Reserve (PET-cCTA-cFFR)

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST PET-cCTA-cFFR

Study Locations (1)

Missouri

  • Washington University - St Louis

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2019-06-06
Est. Completion 2023-07-18
Phase NA

What the Registry Record Tells You About NCT05349084

The ClinicalTrials.gov registry entry for NCT05349084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (98% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which PET-cCTA-cFFR is the first listed.

NCT05349084 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05349084 about?

NCT05349084 is a clinical study titled "PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR". The broad, long-term objective of this pilot study is to develop an optimal, clinically usable, non-invasive evaluation of Coronary Artery Disease (CAD) in the setting of stable angina which provides both anatomic and functional information. Patients already scheduled to undergo Invasive coronary c...

What is the current status of trial NCT05349084?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-06-06. Estimated completion is 2023-07-18.

What conditions does trial NCT05349084 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT05349084?

The interventions under investigation include: PET-cCTA-cFFR (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05349084?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05349084 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.